We are live on
!
Find out more
DZ Bank Portfolio holdings
AUM
$130B
1-Year Est. Return
46.38%
This Fund
S&P 500
This Quarter
Est. Return
+5.98%
1 Year Est. Return
+46.38%
3 Year Est. Return
+181.64%
5 Year Est. Return
+275.03%
10 Year Est. Return
–
AUM
$32.4B
AUM Growth
+$1.6B
(+5.2%)
Cap. Flow
-$722M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
26.38%
Holding
812
New
60
Increased
215
Reduced
231
Closed
62
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$589M |
| 2 |
Autodesk
ADSK
|
+$287M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$242M |
| 4 |
Boston Scientific
BSX
|
+$222M |
| 5 |
Fidelity National Information Services
FIS
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nutrien
NTR
|
+$297M |
| 2 |
Alibaba
BABA
|
+$251M |
| 3 |
Deere & Co
DE
|
+$242M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$220M |
| 5 |
Las Vegas Sands
LVS
|
+$217M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.58% |
| 2 | Healthcare | 17.55% |
| 3 | Technology | 16.19% |
| 4 | Consumer Discretionary | 10.59% |
| 5 | Materials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HES
76
DELISTED
Hess
HES
| $102M | 0.31% |
1,598,278
-772,488
| -33% | -$47.8M |
|
77
Colgate-Palmolive
CL
$72.3B
| $101M | 0.31% |
1,412,413
-14,613
| -1% | -$1.04M |
|
78
Starbucks
SBUX
$123B
| $99.8M | 0.31% |
1,190,337
-105,871
| -8% | -$8.3M |
|
79
Accenture
ACN
$116B
| $98M | 0.3% |
530,147
+23,687
| +5% | +$4.25M |
|
80
Equinix
EQIX
$103B
| $96.9M | 0.3% |
192,196
+191,228
| +19,755% | +$91.7M |
|
81
American Financial Group
AFG
$11.9B
| $96.9M | 0.3% |
945,682
-205,160
| -18% | -$20.6M |
|
82
Verizon
VZ
$208B
| $96.3M | 0.3% |
1,686,134
-2,857,421
| -63% | -$165M |
|
83
Qiagen
QGEN
$8.9B
| $93.6M | 0.29% |
2,171,654
-381,500
| -15% | -$15.8M |
|
84
Texas Instruments
TXN
$237B
| $90.6M | 0.28% |
789,470
-1,572,158
| -67% | -$176M |
|
85
Bristol-Myers Squibb
BMY
$136B
| $87.6M | 0.27% |
1,930,969
+294,800
| +18% | +$13.7M |
|
86
Intel
INTC
$475B
| $86.7M | 0.27% |
1,815,268
-186,664
| -9% | -$9.26M |
|
87
Western Digital
WDC
$166B
| $85.4M | 0.26% |
2,375,211
+2,367,934
| +32,540% | +$81.2M |
|
88
Deutsche Bank
DB
$75.9B
| $85M | 0.26% |
11,011,075
-484,081
| -4% | -$3.73M |
|
89
Omnicom Group
OMC
$24.3B
| $84.4M | 0.26% |
1,029,899
-18,092
| -2% | -$1.43M |
|
90
AT&T
T
$178B
| $83.6M | 0.26% |
3,313,551
-15,109
| -0.5% | -$362K |
|
91
Gilead Sciences
GILD
$181B
| $81.7M | 0.25% |
1,209,166
-604,232
| -33% | -$39.7M |
|
92
Fluor
FLR
$7.11B
| $70.1M | 0.22% |
2,081,892
-283,554
| -12% | -$9.5M |
|
93
Medtronic
MDT
$117B
| $70.1M | 0.22% |
720,014
+29,446
| +4% | +$2.69M |
|
94
Vulcan Materials
VMC
$35.6B
| $68.6M | 0.21% |
499,732
+498,032
| +29,296% | +$63.6M |
|
95
AbbVie
ABBV
$452B
| $66.2M | 0.2% |
910,050
+222,584
| +32% | +$17.5M |
|
96
iShares Europe ETF
IEV
$1.69B
| $60.8M | 0.19% |
1,379,822
+476,648
| +53% | +$21M |
|
97
Fidelity National Financial
FNF
$12.8B
| $57.1M | 0.18% |
1,472,495
-34,200
| -2% | -$1.29M |
|
98
American Tower
AMT
$82.1B
| $55.1M | 0.17% |
269,722
+251,663
| +1,394% | +$50.6M |
|
99
Baxter International
BAX
$13.5B
| $54.7M | 0.17% |
668,079
-51,374
| -7% | -$3.99M |
|
100
MetLife
MET
$61.4B
| $54.3M | 0.17% |
1,092,804
-86,552
| -7% | -$4.07M |
|
Similar funds
DZ Bank's Q2 2019 Portfolio in Review
As of Q2 2019, DZ Bank held 812 positions worth $32.4B, up 5.2% from $30.8B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
DZ Bank's Q2 2019 filing shows 60 new, 215 increased, 231 reduced and 62 closed positions. Its largest new stake was Martin Marietta Materials: 594,917 shares worth $137M. The largest sale was Nutrien, an estimated $297M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Technology.
- DZ Bank's largest Q2 2019 buy was Martin Marietta Materials: 594,917 shares worth $137M.
- DZ Bank added most to Johnson & Johnson in Q2 2019, an estimated $589M increase.
- DZ Bank's biggest Q2 2019 reduction was Nutrien, cutting an estimated $297M.
- DZ Bank fully exited Agilent Technologies in Q2 2019, selling an estimated $10.9M.
- DZ Bank's ten largest holdings make up 26% of its $32.4B portfolio in Q2 2019.
- DZ Bank opened 60 new positions and closed 62 in Q2 2019.
- DZ Bank's portfolio value rose 5.2% quarter-over-quarter to $32.4B.
Based on DZ Bank's 13F filing for Q2 2019, filed 14 Aug 2019.